COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 16, 2016
app pub date -
Dec 14, 2015
filing date -
Dec 12, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Pharmaceutical compositions and methods of inhibiting tumor cell proliferation of triple-negative (ER−/PR−/HER2−) breast cancer cells and for treating subjects with a form of breast cancer having a triple-negative (ER−/PR−/HER2−) phenotype are provided. The methods include a step of contacting triple-negative breast cancer cells with an effective amount of a composition including Eribulin and CYC065.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully